The Patented Medicine Prices Review Board (PMPRB) is an independent quasi-judicial body established by Parliament in 1987 under the Patent Act (Act). Although the PMPRB is part of the Health Portfolio, because of its quasi-judicial responsibilities it carries out its mandate at arm’s-length from the Minister of Health, who is responsible for the sections of the Act pertaining to the PMPRB.
The PMPRB is a consumer protection agency with a dual regulatory and reporting mandate. Its regulatory mandate is to ensure that the prices of patented medicines sold in Canada are not excessive. Its reporting mandate is to provide stakeholders with pharmaceutical trends information to help them make informed choices.
Contact
Standard Life Centre, 333 Laurier Avenue West, Suite 1400, Ottawa, Ontario, K1P 1C1, Canada
Tel +1 613 288 9635
Website http://www.pmprb-cepmb.gc.ca/
Email PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory body to reconsider their implementation. Companies cite the push for cost-effectiveness as a reason for…
Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), Canada’s federal price regulator for patented medicines, highlights the PMPRB’s mandate to protect consumers against excessive prices for…
See our Cookie Privacy Policy Here
